期刊文献+

联合检测糖化血红蛋白与尿微量白蛋白对糖尿病肾病的临床意义 被引量:2

The clinical significance of HbA1 c and U - mALb combined detection in diabetic nephropathy patients
下载PDF
导出
摘要 目的探讨联合检测糖化血红蛋白与尿微量白蛋白对早期诊断治疗糖尿病肾病有重要临床意义。方法采用高效液相色谱法、免疫比浊法检测了117例糖尿痛患者与91例健康对照者体内的糖化血红蛋白与尿微量白蛋白的水平。按照HbAlc水平离低将这117例DM患者分为低值组(1丑)A1c〈7.O%),中值纽(7%≤HbAIC≤10%)和高值组(HbAlc〉10%),HbAlc水平与糖尿痛肾病发病率进行比较,探讨糖尿病肾痛发生与HbAlc高低之间的关系。结果糖化血红蛋白与尿微量白蛋白的水平在2型糖尿痛组高于健康对照组,差异有统计学意义,HbAlc水平与糖尿病肾病发病率成呈正相关(P〈0.01)。结论DM患者HbAlc水平和U—mAlb水平呈正相关关系,两者的水平与DM患者的早期肾脏损伤程度密切相关,二者联舍捡测对DN的早期诊断、早期治疗及监测有着重要意义。 Objective To discuss the clinical significance of glycosylated hemoglobin Alc ( HbA1c ) and microalbumin - uria ( U - mAtb ) combined detection with diabetic nephropathy (DN). Methods HbAI c and U - mAlb in 117 patients with diabetes mellitus(DM) and 91 healthy individuals, as normal control were examined. The test of HbAlc was completed by High Performance Liquid Chromatography ( HPLC)and im-anme turbidity method was used to detect U - mAlb. According to HhAlc levels, the DM patients were divided into low (HbA1 c 〈 7.0% ), medium(7% ≤ HbAlc≤ 10%)and high value(HbAlc 〉 10% )groups. The differences indience of diabetic nephropathy among tile 3 groups were corn - pared. Results The levels of HbA1 c and U - mAlb were significantly higher in DM group than tht,se of normal control group( P 〈 0. 01 ). incidence of diabetic nephropathy presented a rising trend with the increase of HbAI c, which had a significant positive correlation( P 〈 0. 01 ). Conclusions In DM patients, HbA1 e levels and the levels of U - mAlb have a positive correlation, their levels are closely related to the early injure of kidney with DM. Combined detection of HbA1 c and U - mAlb has an important clinic significance to the early diagnosis, treat-ment and controlling of DN.
作者 罗明达
出处 《医学检验与临床》 2012年第3期24-26,共3页 Medical Laboratory Science and Clinics
关键词 尿微量白蛋白 糖化血红蛋白 糖尿病肾病 Microalbuminur Glycosylated hemoglobin Diabetic nephropathyia
  • 相关文献

参考文献8

二级参考文献37

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:254
  • 2沈琪琳 魏明竟 张秀明 李健斋 魏明竟.尿微量白蛋白[A].张秀明,李健斋,魏明竟.现代l临床生化检验学[C].北京:人民军医出版社,2001.29-34.
  • 3Yamada T, Sato A, Nishimori T, et al. Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes[J].Diabetes Res Clin Pract, 2000, 49 (1) : 23-31.
  • 4Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients [J]. Arteriosclerosis Thromb and Vascular Biol, 2000, 20(6) : 1595-1599.
  • 5[2]Sacks DB,Bruns DE,Goldstein DE,et al.Guidelines and recommendation for laboratory analysis in the diagnosis and management diabetes mellitus[J].Clin Chem,2002,48 (3):436-472.
  • 6[4]Randers E,Erlandsen EJ.Serum cystatin C as an endogenous maker of the renal function--a review[J].Clin Chem Leb Med,1999,37(4):389-395.
  • 7[5]Renders E,Erlandsen EJ.Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function[J].Clin Nephrol,2000,54 (3):203-209.
  • 8[6]Dharnidharka VR,Kwon C,Steven G.Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis[J].Am J Kidney Dis,2002,40 (2):221-226.
  • 9[7]Perlemonine C,Beauvieux MC,Rigalleau V,et al.Interest of cystatin C in screening diabetic patients for early impairment of renal function[J].Metabolism,2003,52 (10):1258-1264.
  • 10[8]Mussap M,Dalla VM,Fioretto P,et al.Cystatin C is a more sensitive marker than creatinine for the eatimation of GFR in type 2 diabetic patients[J].Kidney Int,2002,61(4):1453-1461.

共引文献154

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部